» Articles » PMID: 35662223

A Multiple-tissue-specific Magnetic Resonance Imaging Model for Diagnosing Parkinson's Disease: a Brain Radiomics Study

Abstract

Brain radiomics can reflect the characteristics of brain pathophysiology. However, the value of T1-weighted images, quantitative susceptibility mapping, and R2* mapping in the diagnosis of Parkinson's disease (PD) was underestimated in previous studies. In this prospective study to establish a model for PD diagnosis based on brain imaging information, we collected high-resolution T1-weighted images, R2* mapping, and quantitative susceptibility imaging data from 171 patients with PD and 179 healthy controls recruited from August 2014 to August 2019. According to the inclusion time, 123 PD patients and 121 healthy controls were assigned to train the diagnostic model, while the remaining 106 subjects were assigned to the external validation dataset. We extracted 1408 radiomics features, and then used data-driven feature selection to identify informative features that were significant for discriminating patients with PD from normal controls on the training dataset. The informative features so identified were then used to construct a diagnostic model for PD. The constructed model contained 36 informative radiomics features, mainly representing abnormal subcortical iron distribution (especially in the substantia nigra), structural disorganization (e.g., in the inferior temporal, paracentral, precuneus, insula, and precentral gyri), and texture misalignment in the subcortical nuclei (e.g., caudate, globus pallidus, and thalamus). The predictive accuracy of the established model was 81.1 ± 8.0% in the training dataset. On the external validation dataset, the established model showed predictive accuracy of 78.5 ± 2.1%. In the tests of identifying early and drug-naïve PD patients from healthy controls, the accuracies of the model constructed on the same 36 informative features were 80.3 ± 7.1% and 79.1 ± 6.5%, respectively, while the accuracies were 80.4 ± 6.3% and 82.9 ± 5.8% for diagnosing middle-to-late PD and those receiving drug management, respectively. The accuracies for predicting tremor-dominant and non-tremor-dominant PD were 79.8 ± 6.9% and 79.1 ± 6.5%, respectively. In conclusion, the multiple-tissue-specific brain radiomics model constructed from magnetic resonance imaging has the ability to discriminate PD and exhibits the advantages for improving PD diagnosis.

Citing Articles

Radiomics-based Modelling Unveils Cerebellar Involvement in Parkinson's Disease.

Chen Y, Qi Y, Hu Y, Qiu T, Liu M, Jia Q Cerebellum. 2025; 24(2):48.

PMID: 39964592 DOI: 10.1007/s12311-025-01797-z.


White matter biomarker for predicting de novo Parkinson's disease using tract-based spatial statistics: a machine learning-based model.

Zhang Q, Wang H, Shi Y, Li W Quant Imaging Med Surg. 2024; 14(4):3086-3106.

PMID: 38617147 PMC: 11007501. DOI: 10.21037/qims-23-1478.


A rapid multi-parametric quantitative MR imaging method to assess Parkinson's disease: a feasibility study.

Duan M, Pan R, Gao Q, Wu X, Lin H, Yuan J BMC Med Imaging. 2024; 24(1):58.

PMID: 38443786 PMC: 10916029. DOI: 10.1186/s12880-024-01229-0.


The differential diagnosis value of radiomics-based machine learning in Parkinson's disease: a systematic review and meta-analysis.

Bian J, Wang X, Hao W, Zhang G, Wang Y Front Aging Neurosci. 2023; 15:1199826.

PMID: 37484694 PMC: 10357514. DOI: 10.3389/fnagi.2023.1199826.


Sex modulates the outcome of subthalamic nucleus deep brain stimulation in patients with Parkinson's disease.

Yuan T, Chen Y, Liu D, Ma R, Zhang X, Du T Neural Regen Res. 2022; 18(4):901-907.

PMID: 36204861 PMC: 9700096. DOI: 10.4103/1673-5374.353506.

References
1.
Langkammer C, Pirpamer L, Seiler S, Deistung A, Schweser F, Franthal S . Quantitative Susceptibility Mapping in Parkinson's Disease. PLoS One. 2016; 11(9):e0162460. PMC: 5012676. DOI: 10.1371/journal.pone.0162460. View

2.
Du G, Liu T, Lewis M, Kong L, Wang Y, Connor J . Quantitative susceptibility mapping of the midbrain in Parkinson's disease. Mov Disord. 2015; 31(3):317-24. PMC: 5315570. DOI: 10.1002/mds.26417. View

3.
Plaschke R, Cieslik E, Muller V, Hoffstaedter F, Plachti A, Varikuti D . On the integrity of functional brain networks in schizophrenia, Parkinson's disease, and advanced age: Evidence from connectivity-based single-subject classification. Hum Brain Mapp. 2017; 38(12):5845-5858. PMC: 5931403. DOI: 10.1002/hbm.23763. View

4.
Diederich N, Surmeier D, Uchihara T, Grillner S, Goetz C . Parkinson's disease: Is it a consequence of human brain evolution?. Mov Disord. 2019; 34(4):453-459. PMC: 6593760. DOI: 10.1002/mds.27628. View

5.
Tang Y, Meng L, Wan C, Liu Z, Liao W, Yan X . Identifying the presence of Parkinson's disease using low-frequency fluctuations in BOLD signals. Neurosci Lett. 2017; 645:1-6. DOI: 10.1016/j.neulet.2017.02.056. View